Abstract
The validation of the selective, potent and systemically active non-competitive mGlu1 antagonists YM-298198 and JNJ16259685 in a physiological functional assay will facilitate elucidation of this receptor's role in brain function and as a potential drug target.
MeSH terms
-
Benzimidazoles / pharmacology*
-
Brain / physiology
-
Drug Delivery Systems
-
Electrophysiology
-
Humans
-
Quinolines / pharmacology*
-
Receptors, Metabotropic Glutamate / antagonists & inhibitors*
-
Receptors, Metabotropic Glutamate / physiology
-
Synaptic Transmission
-
Thiazoles / pharmacology*
Substances
-
(3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone
-
6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2-carboxamide
-
Benzimidazoles
-
Quinolines
-
Receptors, Metabotropic Glutamate
-
Thiazoles
-
metabotropic glutamate receptor type 1